Chu Tak-Ho, Midha Rajiv
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Muscle Nerve. 2023 Feb;67(2):177-181. doi: 10.1002/mus.27769. Epub 2022 Dec 22.
INTRODUCTION/AIMS: We have recently isolated and expanded skin-derived Schwann cells (Sk-SCs) from human skin and showed that they are largely similar to nerve-derived Schwann cells (N-SCs). Here, we extend our investigation into functional assessments of the nude rats that received human Sk-SCs and N-SCs after intraneural delivery into crushed and decellularized tibial nerve in adult nude rats.
Sk-SCs, N-SCs, dermal fibroblasts, or control culture medium was injected into the crushed and decellularized tibial nerve using in situ repeated freeze-thaw cycles. Animals were then subjected to a ladder rung walking test, nociceptive von Frey testing, and walking gait analysis weekly. Animals were euthanized 6 weeks after surgery, gastrocnemius and soleus muscles were weighed, distal nerves were harvested, and whole semithin cross-sections were analyzed using segmentation software.
N-SC-injected and dermal fibroblast-injected animals improved significantly at 4 to 6 weeks postinjury in nociceptive assessment compared with medium-injected controls. Sk-SCs recovered more rapidly in tibial functional index at 2 weeks postinjury compared with medium-injected controls. No significant difference was observed for the ladder rung walking test or muscle weight ratio. Histologically, the number of myelinated axons was significantly higher in all cell injection groups compared with medium-injected controls. No significant difference was observed in g ratio, axon diameter, or myelin thickness.
Cell injection significantly improved axon regeneration across an in situ decellularized nerve segment. However, a more human cell-permissive animal model is required to delineate functional differences between cell types for preclinical transplantation studies.
引言/目的:我们最近从人皮肤中分离并扩增了皮肤源雪旺细胞(Sk-SCs),并表明它们在很大程度上与神经源雪旺细胞(N-SCs)相似。在此,我们将研究扩展至对成年裸鼠进行神经内注射人Sk-SCs和N-SCs后的功能评估,这些裸鼠的胫神经已被挤压并脱细胞。
利用原位反复冻融循环将Sk-SCs、N-SCs、真皮成纤维细胞或对照培养基注射到挤压并脱细胞的胫神经中。然后每周对动物进行阶梯行走试验、伤害性冯·弗雷试验和行走步态分析。术后6周对动物实施安乐死,称量腓肠肌和比目鱼肌的重量,采集远端神经,并使用分割软件分析整个半薄切片。
与注射培养基的对照组相比,注射N-SCs和真皮成纤维细胞的动物在损伤后4至6周的伤害性评估中显著改善。与注射培养基的对照组相比,Sk-SCs在损伤后2周时胫功能指数恢复得更快。阶梯行走试验或肌肉重量比未观察到显著差异。组织学上,与注射培养基的对照组相比,所有细胞注射组的有髓轴突数量显著更高。在g比值、轴突直径或髓鞘厚度方面未观察到显著差异。
细胞注射显著改善了原位脱细胞神经段的轴突再生。然而,需要一个更适合人类细胞的动物模型来界定细胞类型之间的功能差异,以进行临床前移植研究。